【摘要】 本文对我国医药制造业的市场集中度、进出壁垒、差异化进行分析,根据所收集的资料,以销售收入为指标计算市场集中度,明确我国医药制造业的市场结构为分散竞争型产业。从结构差异、产品差异两个角度进行差异化分析,医药制造业的产品差异较小,但是地区结构差异较大。从规模经济壁垒、技术壁垒、必要资本壁垒和政策壁垒四个方面分析医药制造业的进出壁垒,说明我国医药制造业最大的进入壁垒在于政策壁垒。对调整和改善医药制造业目前不合理的市场结构从产业规划和政策两个方面提出建议和对策,从而促进医药制造业良性竞争和健康发展。更多还原

【Abstract】 This paper analyzed the market concentration, access barriers and differentiation of China’s pharmaceutical manufacturing industry. Based on the information collected, took sale revenue as the indicator to calculate the market concentration and find that the market structure of China’s pharmaceutical manufacturing industry was decentralized competitive market. Differentiation analysis was conducted from the perspective of structural differences and product differences. It was found that pharmaceutical manufacturing industry was of little product differences, but large regional differences in structure. Access barriers to pharmaceutical industry were analyzed from the perspective of economies of scale barriers, technical barriers, essential capital barriers and policy barriers. It was found that greatest barrier to pharmaceutical manufacturing was policy barrier. Proposals and strategies for adjusting and improving the unreasonable market structure of China’s pharmaceutical manufacturing industry were put forward from the perspective of industrial planning and policy so as to promote healthy competition and development for the pharmaceutical manufacturing industry.更多还原